Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CyberKnife for hilar lung tumors: report of clinical response and toxicity.
Unger K, Ju A, Oermann E, Suy S, Yu X, Vahdat S, Subramaniam D, Harter KW, Collins SP, Dritschilo A, Anderson E, Collins BT. Unger K, et al. Among authors: oermann e. J Hematol Oncol. 2010 Oct 22;3:39. doi: 10.1186/1756-8722-3-39. J Hematol Oncol. 2010. PMID: 20969774 Free PMC article.
Health system-scale language models are all-purpose prediction engines.
Jiang LY, Liu XC, Nejatian NP, Nasir-Moin M, Wang D, Abidin A, Eaton K, Riina HA, Laufer I, Punjabi P, Miceli M, Kim NC, Orillac C, Schnurman Z, Livia C, Weiss H, Kurland D, Neifert S, Dastagirzada Y, Kondziolka D, Cheung ATM, Yang G, Cao M, Flores M, Costa AB, Aphinyanaphongs Y, Cho K, Oermann EK. Jiang LY, et al. Nature. 2023 Jul;619(7969):357-362. doi: 10.1038/s41586-023-06160-y. Epub 2023 Jun 7. Nature. 2023. PMID: 37286606 Free PMC article.
CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.
Vahdat S, Oermann EK, Collins SP, Yu X, Abedalthagafi M, Debrito P, Suy S, Yousefi S, Gutierrez CJ, Chang T, Banovac F, Anderson ED, Esposito G, Collins BT. Vahdat S, et al. J Hematol Oncol. 2010 Feb 4;3:6. doi: 10.1186/1756-8722-3-6. J Hematol Oncol. 2010. PMID: 20132557 Free PMC article. Clinical Trial.
A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.
Oermann EK, Slack RS, Hanscom HN, Lei S, Suy S, Park HU, Kim JS, Sherer BA, Collins BT, Satinsky AN, Harter KW, Batipps GP, Constantinople NL, Dejter SW, Maxted WC, Regan JB, Pahira JJ, McGeagh KG, Jha RC, Dawson NA, Dritschilo A, Lynch JH, Collins SP. Oermann EK, et al. Technol Cancer Res Treat. 2010 Oct;9(5):453-62. doi: 10.1177/153303461000900503. Technol Cancer Res Treat. 2010. PMID: 20815416 Free article.
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer.
Oermann EK, Suy S, Hanscom HN, Kim JS, Lei S, Yu X, Zhang G, Ennis B, Rohan JP, Piel N, Sherer BA, Borum D, Chen VJ, Batipps GP, Constantinople NL, Dejter SW, Bandi G, Pahira J, McGeagh KG, Adams-Campbell L, Jha R, Dawson NA, Collins BT, Dritschilo A, Lynch JH, Collins SP. Oermann EK, et al. J Hematol Oncol. 2011 Mar 27;4:12. doi: 10.1186/1756-8722-4-12. J Hematol Oncol. 2011. PMID: 21439088 Free PMC article.
Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach.
Gill B, Oermann E, Ju A, Suy S, Yu X, Rabin J, Kalhorn C, Nair MN, Voyadzis JM, Unger K, Collins SP, Harter KW, Collins BT. Gill B, et al. Among authors: oermann e. Front Oncol. 2012 Apr 26;2:39. doi: 10.3389/fonc.2012.00039. eCollection 2012. Front Oncol. 2012. PMID: 22645718 Free PMC article.
142 results